Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Asia Diagnostics Summit 2018

Takahiro Ochiya's Biography



Takahiro Ochiya, Chief, National Cancer Center Research Institute Japan

Dr. Ochiya carried a councilor of Japanese Cancer Association. After he got Ph.D. in 1988 in Osaka University and then went to do a post-doc at La Jolla Cancer Research (SF Burnham Institute for Medical Research), CA, USA. Dr. Ochiya’s lab focuses the development of novel animal models, methods, and strategies to study cancer development and metastasis. Especially, current focuses are siRNA- and microRNA-based therapy and exosome-mediated tumor metastasis. Dr. Ochiya has authored more than 260 peer-reviewed publications including 40 review articles, holds 24 Japan and 12 U.S. & Europe patents, and contributed to several books on stem cells, Extracellular vesicles, and RNAi medicine. Dr. Ochiya is a chief scientist of current Japan project of the Development of Diagnostic Technology for Detection of miRNA in Body Fluids (supported by NEDO/AMED).

Takahiro Ochiya Image

Exosome Diagnosis Presents a Novel Platform for Liquid Biopsy

Monday, 5 November 2018 at 09:00

Add to Calendar ▼2018-11-05 09:00:002018-11-05 10:00:00Europe/LondonExosome Diagnosis Presents a Novel Platform for Liquid BiopsyAsia Diagnostics Summit 2018 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com

Exosomes are 50-150 nm size in diameter extracellular vesicles (EVs) secreted by multiple living cells into the extracellular space. They contain tissue or cell-specific bioactive materials, including DNAs, mRNAs, ncRNAs, proteins, lipids, metabolites, etc. with their specific surface markers, such as, CD9, CD63, CD81, Alix, etc. Exosomes have been considered as information carriers in cell communication between cancer cells and non-cancer cells, which affect gene expressions and cellular signalling pathways of recipient cells by delivering their contents. Exosomes are promising tools for improving cancer care, but conversely may also contribute to tumor progression. Here, we highlight recently discovered roles of exosomes in modulating cancer microenvironment. We also discuss how exosomes could be exploited as biomarkers for a novel platform of liquid biopsy and delivery vehicles in cancer therapy.


Add to Calendar ▼2018-11-05 00:00:002018-11-06 00:00:00Europe/LondonAsia Diagnostics Summit 2018Asia Diagnostics Summit 2018 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com